143 related articles for article (PubMed ID: 20560956)
21. The importance of Notch signaling in peripheral T-cell lymphomas.
Kamstrup MR; Biskup E; Gjerdrum LM; Ralfkiaer E; Niazi O; Gniadecki R
Leuk Lymphoma; 2014 Mar; 55(3):639-44. PubMed ID: 23697875
[TBL] [Abstract][Full Text] [Related]
22. Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression.
Levi E; Wang Z; Petrogiannis-Haliotis T; Pfeifer WM; Kempf W; Drews R; Kadin ME
J Invest Dermatol; 2000 Dec; 115(6):1034-40. PubMed ID: 11121138
[TBL] [Abstract][Full Text] [Related]
23. Suppression of the notch signaling pathway by γ-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation.
Chen SM; Liu JP; Zhou JX; Chen C; Deng YQ; Wang Y; Tao ZZ
Cancer Lett; 2011 Jul; 306(1):76-84. PubMed ID: 21420785
[TBL] [Abstract][Full Text] [Related]
24. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
25. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
26. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
[TBL] [Abstract][Full Text] [Related]
28. Gamma-secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses.
Kang JH; Kim BS; Uhm TG; Lee SH; Lee GR; Park CS; Chung IY
Am J Respir Crit Care Med; 2009 May; 179(10):875-82. PubMed ID: 19234107
[TBL] [Abstract][Full Text] [Related]
29. CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL.
Plaza JA; Ortega P; Lynott J; Mullane M; Kroft S; Olteanu H
Am J Dermatopathol; 2010 Jul; 32(5):489-91. PubMed ID: 20442639
[TBL] [Abstract][Full Text] [Related]
30. Notch-regulation upon Dll4-stimulation of TGFb-induced apoptosis and gene expression in human B-cell non-Hodgkin lymphomas.
Hajdu M; Kopper L; Sebestyén A
Scand J Immunol; 2010 Jan; 71(1):29-37. PubMed ID: 20017807
[TBL] [Abstract][Full Text] [Related]
31. CD30
Sauder MB; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2017 Apr; 31(2):317-334. PubMed ID: 28340881
[TBL] [Abstract][Full Text] [Related]
32. Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells.
Schwarzer R; Dörken B; Jundt F
Leukemia; 2012 Apr; 26(4):806-13. PubMed ID: 21946908
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma--is it a new variant?
Kumaran MS; Jithendriya M; Nagaraj P; Tirumalae R; Jayaseelan E
Indian J Dermatol Venereol Leprol; 2012; 78(3):354-7. PubMed ID: 22565437
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of Notch signaling by gamma-secretase inhibition can abrogate chemotherapy-induced apoptosis in T-ALL cell lines.
Liu S; Breit S; Danckwardt S; Muckenthaler MU; Kulozik AE
Ann Hematol; 2009 Jul; 88(7):613-21. PubMed ID: 19057901
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Notch signaling pathway enhanced the radiosensitivity of breast cancer cells.
Peng JH; Wang XL; Ran L; Song JL; Zhang ZT; Liu X; Li HY
J Cell Biochem; 2018 Nov; 119(10):8398-8409. PubMed ID: 29904942
[TBL] [Abstract][Full Text] [Related]
36. γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer.
Mizugaki H; Sakakibara-Konishi J; Ikezawa Y; Kikuchi J; Kikuchi E; Oizumi S; Dang TP; Nishimura M
Br J Cancer; 2012 Jun; 106(12):1953-9. PubMed ID: 22596234
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy.
Nefedova Y; Sullivan DM; Bolick SC; Dalton WS; Gabrilovich DI
Blood; 2008 Feb; 111(4):2220-9. PubMed ID: 18039953
[TBL] [Abstract][Full Text] [Related]
38. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor.
Osipo C; Patel P; Rizzo P; Clementz AG; Hao L; Golde TE; Miele L
Oncogene; 2008 Aug; 27(37):5019-32. PubMed ID: 18469855
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous anaplastic large cell lymphoma with angioinvasive features and cytotoxic phenotype: a rare lymphoma variant within the spectrum of CD30+ lymphoproliferative disorders.
Kempf W; Kazakov DV; Paredes BE; Laeng HR; Palmedo G; Kutzner H
Dermatology; 2013; 227(4):346-52. PubMed ID: 24246691
[TBL] [Abstract][Full Text] [Related]
40. [Primary cutaneous anaplastic CD30+ large cell lymphoma].
Marrero-Calvo MD; Rodríguez-Serna M; Castejón-Calvete P; Peláez-Malagón S
Actas Dermosifiliogr; 2007 Apr; 98(3):194-7. PubMed ID: 17504705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
